Analgesics in Uruguay

Analgesics in Uruguay


Though current value sales are expected to rise, constant value sales are expected to fall, as continuing rising operating costs cut into profitability. In 2023, with concerns about COVID-19 abating, demand for analgesics reduces to more normal levels, after heightened sales during the pandemic. In addition, acetaminophen continues to account for most volume sales, as it is considered safe and is also easily accessible as on OTC drug.

Euromonitor International's Analgesics in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Analgesics in Uruguay
Euromonitor International
October 2023
List Of Contents And Tables
ANALGESICS IN URUGUAY
KEY DATA FINDINGS
2023 DEVELOPMENTS
Fall in constant value sales
Aspirin registers significant fall in volume sales
Gramon Bagó strong performer in 2023, due to extensive acetaminophen offerings
PROSPECTS AND OPPORTUNITIES
Muted growth in mature, competitive product area
Increasing competition from herbal/traditional products
Generic analgesics increasingly popular
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2018-2023
Table 2 Sales of Analgesics by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Analgesics: % Value 2019-2023
Table 4 LBN Brand Shares of Analgesics: % Value 2020-2023
Table 5 Forecast Sales of Analgesics by Category: Value 2023-2028
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN URUGUAY
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2018-2023
Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 13 Distribution of Consumer Health by Format: % Value 2018-2023
Table 14 Distribution of Consumer Health by Format and Category: % Value 2023
Table 15 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings